Next Article in Journal
Epigenetics and Mechanobiology in Heart Development and Congenital Heart Disease
Next Article in Special Issue
Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
Previous Article in Journal
The Prevalence and Correlation of Carotid Artery Calcifications and Dental Pulp Stones in a Saudi Arabian Population
Previous Article in Special Issue
Dirt, Saliva and Leprosy: Anti-Inflammatory and Anti-Infectious Effects
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diseases
Volume 7
Issue 3
10.3390/diseases7030051
diseases-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Mechanism of Fibrosis Induced by Echinococcus spp.

by
Fuqiu Niu
1,
Shigui Chong
2,
Mingqun Qin
3,
Shenmei Li
2,
Riming Wei
4,* and
Yumin Zhao
1,*
1
Department of Parasitology, School of Basic Medicine, Guilin Medical University, Guangxi 541004, China
2
School of Stomatology, Guilin Medical University, Guangxi 541004, China
3
School of Biotechnology, Guilin Medical University, Guangxi 541004, China
4
Department of Nursing teaching and Research, Guilin Medical University, Guangxi 541004, China
*
Authors to whom correspondence should be addressed.
Diseases 2019, 7(3), 51; https://doi.org/10.3390/diseases7030051
Submission received: 7 May 2019 / Revised: 25 July 2019 / Accepted: 8 August 2019 / Published: 12 August 2019
(This article belongs to the Special Issue Chronic Inflammatory and Infectious Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
Infection with Echinococcus spp. causes fibrosis in various vital organs, including the liver and lungs. Hepatic fibrosis is a pathological feature of Echinococcus infection that destroys normal liver tissue, leading to jaundice, cholecystitis, portal hypertension, etc. Severe Echinococcus multilocularis infections lead to liver failure and hepatic encephalopathy. The formation of peripheral fiberboards around the metacestode is a major reason as to why antiparasitic drugs fail to be effectively transported to the lesion site. Studies on the mechanism of hepatic fibrosis caused by Echinococcus are important for treatment in patients. Recent studies have focused on miRNA and TGF-β. More recent findings have focused on the generation of collagen fibers around the metacestode. In this review paper we focus on the mechanism by which the Echinococcus parasite induces fibrosis in liver and some other organs in intermediate hosts—animals as well as human beings.

1. Introduction

Echinococcus spp. includes E. granulosus, E. multilocularis, E. vogeli, E. oligarthrus and E. shiquicus [1]. Patients are only rarely infected with E. vogeli, E. oligarthrus or E. shiquicus [2,3,4]. In this paper, we focus on E. granulosus and E. multilocularis. The eggs released from adult E. granulosus pollute pastures. If the water source is consumed by the intermediate host (cattle, sheep and other herbivores or humans), the oncosphere enters the duodenum through the upper digestive tract. Under suitable conditions, the oncosphere breaks out and enters the intestinal wall, which then reaches the liver and the lung mainly through blood flow, subsequently developing into metacestodes within 3–5 months. Metacestodes of E. granulosus grow slowly and last for several years or decades, mainly in livers or lungs. When dogs, as the definitive host, accidentally eat organs containing metacestodes, protoscoleces are released into the small intestine, and develop into adults to complete their life cycle [5]. The life-cycle of E. multilocularis is similar to that of E. granulosus. Adults live in the small intestine of Vulpes, Canis and Felis, while larvae (metacestodes) migrate in the liver of rodents. As an unsuitable intermediate host, humans become infected by accidental consumption of contaminated food with eggs containing oncospheres [6]. The life-cycles of E. granulosus and E. multilocularis are shown in Figure 1 and Figure 2, respectively [6,7]. E. granulosus and E. multilocularis cause cystic and alveolar echinococcosis, respectively [8]. Both mainly occur in the liver and promote hepatic fibrosis [9,10]. One possible molecular mechanism of E. multilocularis organ tropism towards the liver is that the E. multilocularis tends to migrate to organs with high concentrations of insulin. Indeed, the highest concentrations of insulin in mammals occur at the junction between the portal vein and the liver parenchyma. As an evolutionarily conserved signaling pathway, insulin from the host could interact with receptors of E. multilocularis as ligands. The effect of insulin signaling pathway in E. multilocularis including generation of metacestodes, differentiation of E. multilocularis oncospheres towards the metacestode stage, and ‘re-differentiation’ of E. multilocularis protoscoleces towards the metacestode stage [7].
E. granulosus lesions differ from E. multilocularis as a pathological manifestation. In sheep infected with E. granulosus, the surface of the liver becomes uneven, and the number of protruding vesicles increases. The liver parenchyma has several metacestodes (Figure 3B). A large amount of fluid accumulates in the daughter cysts of metacestodes. In addition to infertile cysts, hydatid sands are visible (Figure 3C). Many protoscoleces can be imaged on slide smears, and some metacestodes become calcified. Our pathological sections and staining of the metacestodes showed that the laminated layer consists of a uniformly red-stained colloidal substance, and the germinal layer is inside the laminated layer, which is composed of irregularly arranged single cells (Figure 4). In another experiment, rodents were infected with E. multilocularis, and the sections prepared from masses in the liver. Pale yellow or white vesicle-like cells could be observed in these sections by gross examination. Multiple metacestodes were connected and aggregated, round or oval, and contained transparent vesicle fluid or gelatinous substances (Figure 3A). A large number of protoscoleces could be imaged under the light microscope. Histological sections and staining showed that numerous metacestodes were clustered into groups. A large number of laminated layers and germinal layers could be detected in these clusters and a majority of germinal layers could be found fallen off these laminated layers. The laminated layer was bent and acellular, and curled up in the vesicle cavity (Figure 5) [11].
Cystic echinococcosis is globally distributed, and high prevalence areas were concentrated in pastoral areas of Eurasia, Africa, America and Oceania. In China, Cystic echinococcosis is prevalent in Qinghai-Tibet Plateau, Inner Mongolia Plateau, Yunnan-Guizhou Plateau and Loess Plateau. Alveolar echinococcosis is distributed in the rural areas located in the northern hemisphere, showing a local epidemic trend. In China, alveolar echinococcosis is distributed in Western Sichuan, Qinghai, Xinjiang, Tibet, Gansu and Ningxia [12]. Alveolar echinococcosis and cystic echinococcosis cause harm to human health and animal husbandry [13,14].
Hepatic fibrosis leads to an imbalance of deposition and degradation of the extracellular matrix (ECM) [15]. The over-deposition of ECM leads to cirrhosis and the loss of liver function. Collagen is the main component of the ECM. Type I and type III collagen account for 60% of liver collagen and are closely related to liver fibrosis. Type I and type III collagen increase during the early stages of hepatic fibrosis, and further increase are seen with the aggravation of hepatic fibrosis [16].
Studies on the pathogenesis of liver fibrosis include histopathological changes, toxicology, cytokines and molecular structures. The activation of hepatic stellate cells (HSCs) is central link to the development of hepatic fibrosis. Various factors (cytokines, growth factors, and enzymes) regulate HSCs and fibroblasts in the liver, leading to their biological dysfunction and subsequent liver fibrosis.

2. Methodology

We collected information from PubMed and CNKI. The key words used in the PubMed database were ‘fibrosis’ and ‘Echinococcus’. We used the Chinese characters ‘fibrosis’ and ‘Echinococcus’ as the key words in the CNKI database. The time range we applied in both two databases was ‘2010–2019′. The references published before 2010 were found in references published during 2010–2019. Some papers were also not used because their topics were mainly about other kinds of pathological changes, or the fibrosis was induced by other parasites. Figure 1 and Figure 2 were taken from the PubMed database by searching for the key words ‘Echinococcus’. Figure 3, Figure 4 and Figure 5 were obtained from our investigations. From August 2004 to September 2007, in the Gansu province, Tibetan Autonomous Prefecture, we performed 2047 necropsies on animal hosts of E. granulosus and E. multilocularis, including 1021 sheep, 331 rodents, 634 yaks and 61 domesticated sheepdogs for pathological and epidemiological studies. We captured rodents by rat clips and sticky rat boards, and sources and species were recorded. After dissection, metacestodes were identified by gross examination and saved. The size, number, location and nature of metacestodes were recorded. Pathologic examinations, isolation and identification of metacestodes were performed in our laboratory. Pathological sections of metacestodes were prepared according to routine procedures. Figure 3A and Figure 5 are from rodents infected with E. multilocularis. We collected random samples of sheep from slaughterhouse and dissected and performed routine examinations by routine laboratory techniques. The samples in Figure 3B,C and Figure 4 were from sheep infected by E. granulosus. Figure 1 and Figure 2 were the results of our epidemiological surveys.

3. Mechanisms of Hepatic Fibrosis Induced by Echinococcus

3.1. MiRNAs Play an Important Role in the Hepatic Fibrosis Induced by Echinococcus

Recent studies have shown that miR-29 regulates hepatic fibrosis and is the regulatory hub for TGF-β and NFκB signaling in HSCs [17,18,19]. Overexpression of microRNA-19b inhibits TGFβRII, inhibiting TGF-β signaling and reducing COL1A1 and α-SMA expression [20]. Select miRNAs promote the migration and activation of HSCs, including miRNA-16, miRNA-195, miRNA-335 and miRNA-181b [21,22,23,24]. Other miRNAs, including miRNA-19b, miRNA-150 and miRNA-29, inhibit HSC activation and ECM synthesis by targeting fibrogenic factors [20,25,26].
Bi and colleagues found that the excretion/secretion products from metacestodes of E. multilocularis upregulate miR-133a and COL1A1, and activate TGF-β/smad signaling to activate HSCs in a mice model [27].
It has been shown in the hepatic tissues of alveolar echinococcosis patients that the expression of α-SMA, COL1A1, COL3A1 and TGFβ II in the adjacent region of the lesions was higher than that of the distal regions [26]. While the expression of miRNA-19b in the lesions was lower in the distal tissues, a negative correlation to COL1A1 was noted [28].
Zhang and colleagues suggested that E. granulosus may inhibit miR-19 liver expression and promote fibrosis through increases in TβRII, the activation of HSCs and ECM production. The experiments were performed with E. granulosus-infected human livers [29].

3.2. TGF-β Plays an Important Role in the Hepatic Fibrosis Induced by Echinococcus

TGF-β is the most important signal transduction pathway during hepatic fibrosis. As the most potent fibrogenic factor, TGF-β is important during HSC transdifferentiation [30,31]. Inhibiting the expression of the TGF-β receptor, TGF-β RII, in particular, inhibits the activation of HSCs [32,33,34,35].
In addition, exogenous hydatid fluid of E. granulosus from alveolar echinococcosis patients were added to cultured LX-2 cells (a type of HSCs) showed that the hydatid fluid promotes cell proliferation through promoting G0/G1 to S phase transition. Exogenous hydatid fluid of E. granulosus could promote the expression of α-SMA, COL1A1, COL3A1 and TGF β RII at the mRNA and protein levels [28].
The downstream Smads of TGF-β1 and its receptors were markedly expressed in periparasitic infiltrates and hepatocytes, which were distant from alveolar echinococcosis lesions [26]. Fibrosis was significant at 180 days post-infection (P.I.) in the periparasitic infiltrates and was present in the liver parenchyma, distant from the lesions. Over the time course of infection, TGF-β1 expression correlated with the CD4/CD8 T-cell ratio previously described as a hallmark of alveolar echinococcosis severity. This suggests that TGF-β plays an important role in alveolar echinococcosis both in immune tolerance against the parasite and during liver fibrosis. These experiments were performed in both a murine alveolar echinococcosis model and in alveolar echinococcosis patients [36].
Other investigators have reported that there are no significant changes during the early stages of E. granulosus infection in the levels of TGF-β1, but significant increases in the levels of TGF-β1 during the middle and late stages of infection were observed. RT-PCR showed that, when compared with the control group, TGF-β1 mRNA levels were low during the early stages of infection, and significantly increased at day 30 P.I. These remained at high levels until day 270. These experiments were performed in mice model [37].

3.3. Collagen Fiber around the Metacestodes of E. granulosus

Histopathological observations from hematoxylin-eosin staining showed that the fibrocyst wall around the metacestode cyst was divided into two layers with clear boundaries. The fibrous layer near the metacestode (inner layer) was a dense, disordered fibrous tissue, often hyaline, lacking blood vessels. Fragments from the laminated layer of the metacestode, epithelioid cells and multinucleated giant cells infiltrated the inner layer, which was surrounded by monocytes, lymphocytes and neutrophils. The fibrous layer near the side of the liver tissue (outer layer) consisted of proliferative fibrous membranes between the liver tissue and the inner layer, which was loosely or compactly arranged. Small blood vessels, bile duct nerves, lymphatic vessels and lymphocytes were scattered in the outer layer. Immunohistochemical staining showed that the expression of type I, III and IV collagen was localized in the outer layer of the fibrocyst wall around the metacestode, showing a brown-yellow sheet distribution, which was occasionally expressed in the inner layer, mostly in a light yellow scattered distribution. The results were obtained from 40 cystic echinococcosis patients [38]. The authors also reported that the mRNA levels of TGF-β 1 and TNF-α in the outer layer were higher than the inner layers [39].
It is proposed that the inner layer is generated through Echinococcus–host immune reactions and foreign body granuloma formation. The outer layer is generated through hepatic fibrosis, induced by the compression of expending metacestodes, through stimulation by parasites, and cytokines from damaged hepatocytes. These specimens were prepared from 40 cystic echinococcosis patients [40].

3.4. Other Hepatic Fibrosis Factors Induced by Echinococcus

Th1-type cytokines promote cell recruitment around larva and participate in chronic cell infiltration, leading to a dense granuloma that eventually progresses into fibrosis and necrosis. Th1 immune responses are the main cause of irreversible fibrosis in the host. The experiments were performed in a murine alveolar echinococcosis model, as well as in human alveolar echinococcosis patients [41].
Another study showed that TNF-α and/or LT-α genes play an essential role in immune protection mechanisms against E. multilocularis at the site of infection in mice model [42].
MMPs (matrix-metallo-proteinases) are zinc-dependent proteases secreted as prozymogen, and are activated to degrade the ECM. In the liver of mice infected with E. granulosus, the expression of MMP2 is high in early post infection and decreases in the middle and late post infection, suggesting that early inflammatory cells secrete proteases including MMP2, reducing the deposition of the ECM. This may be related to the innate immune response. In the late post infection, the expression of MMP2 decreases gradually, and the ECM deposits in large quantities and hepatic fibrosis further develops. The overexpression of MMP2 also leads to the over-activation of HSCs, initiating hepatic fibrosis [43].
Other investigators have found that mammalian FGF, present in the liver and upregulated during fibrosis, could induce the metacestode of E. multilocularis to grow during alveolar echinococcosis by acting on an evolution conserved parasite FGF signaling system (parasite FGF receptors). Growth of metacestodes could stimulate hepatic fibrosis as a vicious circle is created. They also reported that the parasite’s FGF signaling systems are promising targets for the development of novel drugs against alveolar echinococcosis. These experiments showed that tyrosine kinase (TK) inhibitor BIBF 1120, which is used to treat human cancer, could prevent activation of FGF signalling system. In vitro experiments were performed with the natural metacestodes of E. multilocularis (from rodents). Metacestodes were then continuously passaged in mongolian jirds (Meriones unguiculatus) [44].

4. Fibrosis in Other Organs Induced by Echinococcus

Cystic echinococcosis in bone is quite rare (accounting for 0.5–2% of all cases, half of which are in the spine) [45,46,47]. A case of a sacral hydatid cyst was reported as a more uncommon case. The patient was a 19 years old man presenting with cauda equine syndrome and with pelvic pain as a result of constriction from a hydatid cyst with fibrous tissue around it. After surgical resection, the evaluation was good, with recovery of perineal sensation and anal tone. Albendazole is the drug of choice against this disease. When suspected, presurgical use of Albendazole in cystic echinococcosis reduces risk of recurrence and/or facilitates surgery by reducing intracystic pressure. A misdiagnosis of hydatid cyst could be devastating. Hence, hydatid cyst should be kept as a differential diagnosis and when encountered with a cystic lesion of sacrum. In addition, long term follow-up is mandatory as risk of recurrence is high [48].
It has been found that hydatid cyst fluid of E. granulosus could stimulate epithelial to mesenchymal transition in human adenocarcinoma-derived alveolar basal epithelial cell line (A549) when cultured in vitro. It has also been reported that hydatid cyst fluid of E. granulosus could enhance expression of mesenchymal cytoskeletal markers (fibronectin and vimentin) accompanied by a down-regulation of an epithelial marker (E–cadherin gene) in human adenocarcinoma derived alveolar basal epithelial cell line. This indicates that epithelial to mesenchymal cell transition induced by E. granulosus could contribute to fibrotic reactions in lung tissue [49].
In humans, fibrosis in the pericardium induced by Echinococcus may cause consequent pericardial effusion, acute pericarditis, cardiac tamponade or constrictive pericarditis. Additionally, intracardiac rupture of an Echinococcus cyst could cause membrane or secondary cyst embolization in the lungs or organs supplied by the systemic circulation. Although unusual causes of cardiac disease, heart involvement by Echinococcus should be considered in differential diagnosis, especially of myocardial and/or pericardial diseases of unknown etiology, in both immunocompetent and immunocompromised individuals [50].

5. Therapeutics

The restoration of the liver structure has been reported in mice infected by E. granulosus after treatment of 125 pg/mLIL-17A without any visible toxic effects. Lower fibrosis and reduced iNOS, TNF-α, NF-κb and CD68 expression in the hepatic parenchyma of treated mice were also noted [51].
With knowledge of the collagen fiber surrounding the metacestodes of E. granulosus, others have discovered a separable space between the inner and outer layers of fibrocysts stratified round the metacestodes [45]. Xiangmo and colleagues surgically removed more than 100 cases of hydatid cysts (metacestodes) along potential separable spaces between the inner and outer layers of patients infected with E. granulosus. Successful surgical operation can treat patients and remove the metacestodes of E. granulosus completely without damaging the surrounding ductal tissues (e.g., blood vessels and bile ducts) and metacestodes, avoiding recurrence and complications of the residual cavity post-operation [52,53].
Labsi and coworkers reported that the combination of pomegranate peel aqueous and albendazole showed more hydatid cyst growth inhibition; the histological structure of liver improvement and significant iNOS, TNF-α, NF-κβ, vimentin, CD68 decrease expression compared with albendazole-treated groups in mice infected with E. granulosus [54].

6. Conclusions

In recent years, miRNA and TGF-β have been hot spots with respect to investigating the mechanisms by which hepatic fibrosis is induced by Echinococcus spp. A thorough understanding of these mechanisms would be conducive to drug development. Morphological studies of the metacestode of Echinococcus spp. and the fibrocysts surrounding these tissues may lead to a deeper understanding of their generation, and may promote surgical methodologies and other possible interventions.
Still, the molecular mechanisms of parasitic organ tropism are little studied to date. Also, most studies have been focused on the signaling pathways in the host cells. The stimulation from Echinococcus spp. has usually been described as ‘excretion/secretion products’, but not as ligand-specific. Little research has been concerned with how host components interact with Echinococcus spp. and the signaling pathways in the parasite. To clarify and confirm the complete process of the Echinococcus–host interaction, additional studies are required to focus on the parasitic side as well as their involvement in this complex process.

Author Contributions

F.N. searched articles in Pubmed and CNKI, participated in the writing. S.C. and S.L. captured rodents by rat clips and sticky rat boards, recorded source and species, and carried them to the laboratory. Their work count for the accomplishment of Figure 3 and Figure 5. M.Q. and R.W. collected random samples of sheep from slaughterhouse, dissected, and carried them to the laboratory. Their work count for the accomplishment of Figure 4. S.C., M.Q., S.L., R.W., and Y.Z. all participated in preparation of pathological sections of metacestodes, which was used in Figure 3, Figure 4 and Figure 5. Y.Z. take the photos of Figure 3, Figure 4 and Figure 5. This project was sponsored and organized by Y.Z. Y.Z. and R.W. also helped revise this paper.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gao, H. The Study of Relation between Calcium/Angiogeesis Signal Pathway and Growth Status of Hydatid. Master’s Thesis, Lanzhou University, Lanzhou, China, June 2018. [Google Scholar]
  2. Eckert, J.; Gemmell, M.A.; Meslin, F.X.; Pawlowski, Z.S. WHO/OIE manual on echinococcosis in humans and animals: A public health problem of global concern. Int. J. Parasitol. 2001, 31, 1717–1718. [Google Scholar]
  3. Nakao, M.; Lavikainen, A.; Yanagida, T.; Ito, A. Phylogenetic systematics of the genus Echinococcus (Cestoda: Taeniidae). Int. J. Parasitol. 2013, 43, 1017–1029. [Google Scholar] [CrossRef] [PubMed]
  4. Xiao, N.; Qiu, J.M.; NaKao, M.; Li, T.Y.; Chen, X.W.; Schantz, P.M.; Craig, P.S.; Ito, A. Biological Features of a New Echinococcus Species (Echinococcus shiquicus) in the East of Qinghai-Tibet Plateau. Chin. J. Parasitol. Parasit. Dis. 2008, 26, 307–312. [Google Scholar]
  5. Moro, P.; Schantz, P. Echinococcosis: A review. Int. J. Infect. Dis. 2009, 13, 125–133. [Google Scholar] [CrossRef] [PubMed]
  6. Brunetti, E.; Garcia, H.H.; Junghanss, T. Cystic echinococcosis: Chronic, complex, and still neglected. PLoS Negl. Trop. Dis. 2011, 5, e1146. [Google Scholar] [CrossRef] [PubMed]
  7. Wahlstrom, H.; Isomursu, M.; Hallgren, G.; Christensson, D.; Cedersmyg, M.; Wallensten, A.; Hjertqvist, M.; Davidson, R.K.; Uhlhorn, H.; Hopp, P. Combining information from surveys of several species to estimate the probability of freedom from Echinococcus multilocularis in Sweden, Finland and mainland Norway. Acta Vet. Scand. 2011, 53, 9. [Google Scholar] [CrossRef] [PubMed]
  8. Brehm, K.; Koziol, U. Echinococcus-Host Interactions at Cellular and Molecular Levels. Adv. Parasitol. 2017, 95, 147–212. [Google Scholar] [CrossRef] [PubMed]
  9. Craig, P.S.; Mcmanus, D.P.; Lightowlers, M.W.; Chabalgoity, J.A.; Garcia, H.H.; Gavidia, C.M.; Gilman, R.H.; Gonzalez, A.E.; Lorca, M.; Naquira, C. Prevention and control of cystic echinococcosis. Lancet Infect. Dis. 2007, 7, 385–394. [Google Scholar] [CrossRef]
  10. Brunetti, E.; Kern, P.; Vuitton, D.A. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010, 114, 1–16. [Google Scholar] [CrossRef] [PubMed]
  11. Zhao, Y.; Tong, S.; Jing, T.; Chong, S.; Cai, X.; Jing, Z.; Han, J. Investigation on Echinococcosis in Animals in Gannan Tibetan Autonomous Prefecture. Chin. J. Parasitol. Parasit. Dis. 2009, 27, 27–30. [Google Scholar]
  12. Lu, Y.; Huang, Q.; Zhou, Z.; Lu, Y. An overview of parasitic diseases by analyzing publications at National Institue of Parasitic Diseases Control and Prevention in the last five years. Chin. J. Dis. Control Prev. 2015, 19, 86–90. [Google Scholar]
  13. Ito, A.; Urbani, C.; Qiu, J.; Vuitton, D.A.; Qiu, D.; Heath, D.D.; Craig, P.S.; Zheng, F.; Schantz, P.M. Control of echinococcosis and cysticercosis: A public health challenge to international cooperation in China. Acta Trop. 2003, 86, 3–17. [Google Scholar] [CrossRef]
  14. Budke, C.M.; Deplazes, P.; Torgerson, P.R. Global Socioeconomic Impact of Cystic Echinococcosis. Emerg. Infect. Dis. 2006, 12, 296–303. [Google Scholar] [CrossRef] [PubMed]
  15. Lee, U.E.; Friedman, S.L. Mechanisms of Hepatic Fibrogenesis. Best Pract. Res. Clin. Gastroenterol. 2011, 25, 195–206. [Google Scholar] [CrossRef] [PubMed]
  16. Vuitton, D.A.; Guerret-Stocker, S.; Carbillet, J.P.; Mantion, G.; Miguet, J.P.; Grimaud, J.A. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z. Parasitenkd. 1986, 72, 97–104. [Google Scholar] [CrossRef] [PubMed]
  17. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233. [Google Scholar] [CrossRef] [PubMed]
  18. Boldin, M.P.; Baltimore, D. MicroRNAs, new effectors and regulators of NF-κB. Immunol. Rev. 2012, 246, 205–220. [Google Scholar] [CrossRef] [PubMed]
  19. Kwiecinski, M.; Noetel, A.; Elfimova, N.; Trebicka, J.; Schievenbusch, S.; Strack, I.; Molnar, L.; Von, B.M.; Töx, U.; Nischt, R. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE 2011, 6, e24568. [Google Scholar] [CrossRef] [PubMed]
  20. Lakner, A.M.; Steuerwald, N.M.; Walling, T.L.; Ghosh, S.; Li, T.; Mckillop, I.H.; Russo, M.W.; Bonkovsky, H.L.; Schrum, L.W. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 2012, 56, 300–310. [Google Scholar] [CrossRef] [Green Version]
  21. Chen, C.; Wu, C.Q.; Zhang, Z.Q.; Yao, D.K.; Zhu, L. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp. Cell Res. 2011, 317, 1714–1725. [Google Scholar] [CrossRef]
  22. Guo, C.J.; Pan, Q.; Jiang, B.; Chen, G.Y.; Li, D.G. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 2009, 14, 1331. [Google Scholar] [CrossRef] [PubMed]
  23. Sekiya, Y.; Ogawa, T.; Iizuka, M.; Yoshizato, K.; Ikeda, K.; Kawada, N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation. J. Cell. Physiol. 2011, 226, 2535–2542. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, B.; Li, W.; Guo, K.; Xiao, Y.; Wang, Y.; Fan, J. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem. Biophys. Res. Commun. 2012, 421, 4–8. [Google Scholar] [CrossRef] [PubMed]
  25. Sekiya, Y.; Ogawa, T.; Yoshizato, K.; Ikeda, K.; Kawada, N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem. Biophys. Res. Commun. 2011, 412, 74–79. [Google Scholar] [CrossRef] [PubMed]
  26. Zheng, J.; Lin, Z.; Dong, P.; Lu, Z.; Gao, S.; Chen, X.; Wu, C.; Yu, F. Activation of hepatic stellate cells is suppressed by microRNA-150. Int. J. Mol. Med. 2013, 32, 17–24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Bi, X. miR-133a Effect Study on Echinococcus multilocularis Induced Hepatic Stellate Cell Activation In Vitro and Liver Fibrosis in Infected Mice In Vivo. Master’s Thesis, Xinjiang Medical University, Urumchi, China, March 2016. [Google Scholar]
  28. Wang, L. Crosstalk between miR-19b and TGF-β1 Signaling of Hepatic Stellate Cell Proliferation. Master’s Thesis, Xinjiang University, Urumchi, China, June 2014. [Google Scholar]
  29. Zhang, C.; Wang, L.; Ali, T.; Li, L.; Bi, X.; Wang, J.; Lu, G.; Shao, Y.; Vuitton, D.A.; Wen, H.; et al. Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression. Parasit. Vectors 2016, 9, 278. [Google Scholar] [CrossRef] [PubMed]
  30. Brenner, D.A. Molecular pathogenesis of liver fibrosis. Trans. Am. Clin. Climatol. Assoc. 2009, 120, 361–368. [Google Scholar]
  31. Hernandezgea, V.; Friedman, S.L. Pathogenesis of Liver Fibrosis. Annu. Rev. Pathol. 2011, 6, 425–456. [Google Scholar] [CrossRef]
  32. Biernacka, A.; Dobaczewski, M.; Frangogiannis, N.G. TGF-β signaling in fibrosis. Growth Factors 2011, 29, 196–202. [Google Scholar] [CrossRef]
  33. Dooley, S.; Ten, P.D. TGF-β in progression of liver disease. Cell Tissue Res. 2012, 347, 245–256. [Google Scholar] [CrossRef]
  34. Gressner, A.M.; Weiskirchen, R.; Breitkopf, K.; Dooley, S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002, 7, d793. [Google Scholar] [CrossRef]
  35. Ueno, H.; Sakamoto, T.; Nakamura, T.; Qi, Z.; Astuchi, N.; Takeshita, A.; Shimizu, K.; Ohashi, H. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum. Gene Ther. 2000, 11, 33–42. [Google Scholar] [CrossRef] [PubMed]
  36. Wang, J.; Zhang, C.; Wei, X.; Blagosklonov, O.; Lv, G.; Lu, X.; Mantion, G.; Vuitton, D.A.; Wen, H.; Lin, R. TGF-beta and TGF-beta/Smad signaling in the interactions between Echinococcus multilocularis and its hosts. PLoS ONE 2013, 8, e55379. [Google Scholar] [CrossRef]
  37. Liu, Y.; Abudounnasier, G.; Zhang, T.; Liu, X.; Wang, Q.; Yan, Y.; Ding, J.; Wen, H.; Yimiti, D.; Ma, X. Increased Expression of TGF-beta1 in Correlation with Liver Fibrosis during Echinococcus granulosus Infection in Mice. Korean J. Parasitol. 2016, 54, 519–525. [Google Scholar] [CrossRef] [PubMed]
  38. Wu, X.; Chen, X.; Peng, X.; Zhang, S.; Niu, J.; Sun, H. The specific expressions of collagenI, III and IV in the pericystic layer of hepatic hydatid cyst. Chin. J. Zoon. 2004, 876–879. [Google Scholar] [CrossRef]
  39. Wu, X.; Chen, X.; Peng, X.; Zhang, S.; Niu, J.; Sun, H. The special of TGF-β1 and TNF-αin the pericystic layer of hepatic hydatid cysy. Chin. J. End. 2004, 25–27. [Google Scholar] [CrossRef]
  40. Peng, X.; Wu, X.; Zhang, S.; Niu, J. Re-recognition of pathological structure of fibrocyst wall around hepatic hydatid cyst. World Chin. J. Digestol. 2005, 10–13. [Google Scholar] [CrossRef]
  41. Vuitton, D.A. The ambiguous role of immunity in echinococcosis: Protection of the host or of the parasite? Acta Trop. 2002, 85, 119–132. [Google Scholar] [CrossRef]
  42. Amiot, F.; Vuong, P.; Defontaines, M.; Pater, C.; Dautry, F.; Liance, M. Secondary alveolar echinococcosis in lymphotoxin-alpha and tumour necrosis factor-alpha deficient mice: Exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma. Parasite Immunol. 1999, 21, 475–483. [Google Scholar] [CrossRef]
  43. Yan, Y.; Liu, Y.; Yang, N.; Li, B.; Feng, N.; Jiang, T.; Sun, Q.; Wen, H.; Ding, J.; Ma, X. The expression of matrix metalloproteinase 2(MMP2) in mice infected with Echinococcus. Chin. J. Pathog. Biol. 2018, 13, 168–172. [Google Scholar]
  44. Forster, S.; Koziol, U.; Schafer, T.; Duvoisin, R.; Cailliau, K.; Vanderstraete, M.; Dissous, C.; Brehm, K. The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction. PLoS Negl. Trop. Dis. 2019, 13, e0006959. [Google Scholar] [CrossRef]
  45. Abbassioun, K.; Amirjamshidi, A. Diagnosis and Management of Hydatid Cyst of the Central Nervous System: Part 2: Hydatid Cysts of the Skull, Orbit, and Spine. Neurosurg. Q. 2001, 11, 10–16. [Google Scholar] [CrossRef]
  46. Fiennes, A.G.; Thomas, D.G. Combined medical and surgical treatment of spinal hydatid disease: A case report. J. Neurol. Neurosurg. Psychiatry 1982, 45, 927–930. [Google Scholar] [CrossRef]
  47. Sapkas, G.S.; Machinis, T.G.; Chloros, G.D.; Fountas, K.N.; Themistocleous, G.S.; Vrettakos, G. Spinal hydatid disease, a rare but existent pathological entity: Case report and review of the literature. South. Med. J. 2006, 99, 178–183. [Google Scholar] [CrossRef]
  48. Abdelhakim, K.; Khalil, A.; Haroune, B.; Oubaid, M.; Mondher, M. A case of sacral hydatid cyst. Int. J. Surg. Case Rep. 2014, 5, 434–436. [Google Scholar] [CrossRef] [Green Version]
  49. Mohammed, A.A.; Allen, J.T.; Rogan, M.T. Echinococcus granulosus cyst fluid enhances epithelial-mesenchymal transition. Parasite Immunol. 2018, 40, e12533. [Google Scholar] [CrossRef]
  50. Nunes, M.C.; Guimarães Júnior, M.H.; Diamantino, A.C.; Gelape, C.L.; Ferrari, T.C. Cardiac manifestations of parasitic diseases. Heart 2017, 103, 651–658. [Google Scholar] [CrossRef]
  51. Labsi, M.; Soufli, I.; Khelifi, L.; Amir, Z.C.; Touil-Boukoffa, C. In vivo treatment with IL-17A attenuates hydatid cyst growth and liver fibrogenesis in an experimental model of echinococcosis. Acta Trop. 2018, 181, 6–10. [Google Scholar] [CrossRef]
  52. Peng, X.; Zhang, S.; Niu, J.; Wu, X.; Abudu; Pan, H.; Mo, L.; Yang, H. A new principle of wurgical procedures of hepatic hydatid disease—An analysis of 648 cases. Fu Bu Wai Ke 2003, 16, 825–827. [Google Scholar]
  53. Peng, X.; Zhang, S.; Niu, J.; Wu, X.; Pan, H.; Mo, L.; Chen, Y.; Yang, H. Total subadventitial cystectomy for the treatment of 30 patients with hepatic hydatid cyst. Chin. J. Gen. Surg. 2002, 17, 529–530. [Google Scholar]
  54. Labsi, M.; Soufli, I.; Khelifi, L.; Amir, Z.C.; Touil-Boukoffa, C. A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach. Acta Trop. 2019, 197, 105050. [Google Scholar] [CrossRef]
Diseases 07 00051 g001 550
Figure 1. Life cycle of E. granulosus [6]. Copyright notice: The link of original article: (https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001146), the link of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), if any changes were made in the original picture: □Yes ☑No.
Figure 1. Life cycle of E. granulosus [6]. Copyright notice: The link of original article: (https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001146), the link of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), if any changes were made in the original picture: □Yes ☑No.
Diseases 07 00051 g001
Diseases 07 00051 g002 550
Figure 2. Life cycle of E. multilocularis [7]. Copyright notice: The link of original article: (https://actavetscand.biomedcentral.com/articles/10.1186/1751-0147-53-9), the link of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), if any changes were made in the original picture: □Yes ☑No.
Figure 2. Life cycle of E. multilocularis [7]. Copyright notice: The link of original article: (https://actavetscand.biomedcentral.com/articles/10.1186/1751-0147-53-9), the link of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), if any changes were made in the original picture: □Yes ☑No.
Diseases 07 00051 g002
Diseases 07 00051 g003 550
Figure 3. (A) Metacestodes of E. multilocularis in rodents with daughter cysts (→). (B) Uneven surface of the liver containing about 20 metacestodes of E. granulosus (→). (C) Typical metacestodes of E. granulosus with daughter cysts (→) in livers of sheep. Cyst walls showing extensive fibrosis.
Figure 3. (A) Metacestodes of E. multilocularis in rodents with daughter cysts (→). (B) Uneven surface of the liver containing about 20 metacestodes of E. granulosus (→). (C) Typical metacestodes of E. granulosus with daughter cysts (→) in livers of sheep. Cyst walls showing extensive fibrosis.
Diseases 07 00051 g003
Diseases 07 00051 g004 550
Figure 4. Liver pathology of sheep infected by E. granulosus (×400). Note the laminated layer (→) with a glue peptone like appearance in the germinal layer (→).
Figure 4. Liver pathology of sheep infected by E. granulosus (×400). Note the laminated layer (→) with a glue peptone like appearance in the germinal layer (→).
Diseases 07 00051 g004
Diseases 07 00051 g005 550
Figure 5. Liver pathology of the rodents infected with E. multilocularis (×400). Note: numerous metacestodes gather in groups, with germinal and laminated layers. laminated layers dropped from germinal layers. The laminated layers showing belt-shaped without cell structure curling in the cyst (→).
Figure 5. Liver pathology of the rodents infected with E. multilocularis (×400). Note: numerous metacestodes gather in groups, with germinal and laminated layers. laminated layers dropped from germinal layers. The laminated layers showing belt-shaped without cell structure curling in the cyst (→).
Diseases 07 00051 g005

Share and Cite

MDPI and ACS Style

Niu, F.; Chong, S.; Qin, M.; Li, S.; Wei, R.; Zhao, Y. Mechanism of Fibrosis Induced by Echinococcus spp. Diseases 2019, 7, 51. https://doi.org/10.3390/diseases7030051

AMA Style

Niu F, Chong S, Qin M, Li S, Wei R, Zhao Y. Mechanism of Fibrosis Induced by Echinococcus spp. Diseases. 2019; 7(3):51. https://doi.org/10.3390/diseases7030051

Chicago/Turabian Style

Niu, Fuqiu, Shigui Chong, Mingqun Qin, Shenmei Li, Riming Wei, and Yumin Zhao. 2019. "Mechanism of Fibrosis Induced by Echinococcus spp." Diseases 7, no. 3: 51. https://doi.org/10.3390/diseases7030051

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop